Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-30 @ 11:29 AM
Study NCT ID:
NCT04213404
Status:
UNKNOWN
Last Update Posted:
2022-04-21
First Post:
2019-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribociclib and Spartalizumab in R/M HNSCC
Sponsor:
National Taiwan University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-23
First Submit QC Date:
None
Study First Post Date:
2019-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-19
Last Update Post Date:
2022-04-21
Last Update Post Date Type:
ACTUAL